MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Y.
Right arrow Articles by Weiss, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Y.
Right arrow Articles by Weiss, D. S.

Vol. 53, Issue 3, 511-523, March 1998

Substitutions of the Highly Conserved M2 Leucine Create Spontaneously Opening rho 1 gamma -Aminobutyric Acid Receptors

Yongchang Chang and David S. Weiss

Departments of Neurobiology and Physiology & Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294

    Summary
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

All members of the receptor-operated ion channel family that includes gamma -aminobutyric acid (GABA), glycine, nicotinic acetylcholine, and serotonin type 3 receptors have a conserved leucine near the center of the presumed second membrane-spanning domain. This leucine has been postulated to play a role in the gating of the pore. In this study, we examined the effects of mutating this leucine (L301) on the function of human homomeric rho 1 GABA receptors. Oocytes expressing rho 1 GABA receptors in which this leucine was substituted with alanine (A), glycine (G), serine (S), threonine (T), valine, or tyrosine, but not isoleucine or phenylalanine, demonstrated larger-than-normal resting conductances in the absence of GABA. This resting conductance had a reversal potential (and shifted reversal potential with chloride substitution) indistinguishable from that of the wild-type rho 1 GABA-activated current. This resting conductance was antagonized by picrotoxin and, in the case of the A, G, S, and T substitutions, by GABA itself. Although the rho 1 competitive antagonist 3-aminopropyl(methyl)-phosphinic acid did not block the resting conductance, this compound did competitively inhibit the GABA-mediated antagonism of the resting conductance. At higher concentrations, both 3-aminopropyl(methyl)-phosphinic acid and GABA directly activated the A, G, S, and T mutant receptors. Taken together, these data suggest that substitution of this highly conserved leucine with either small or polar residues produced rho 1 GABA receptors that can open in the absence of GABA and support the hypothesis that this leucine may play a key role in the gating of the pore.

    Introduction
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

GABA, glycine, nACh and 5-HT3 receptors are members of a family of ligand-activated ion channels that mediate rapid neurotransmission in the mammalian central nervous system. These receptors are presumed to be pentamers (Langosch et al., 1988; Cooper et al., 1991; Nayeem et al., 1994) composed of subunits that each span the membrane four times (Noda et al., 1983; Grenningloh et al., 1987; Schofield et al., 1987; Maricq et al., 1991) with M2 of each subunit lining the pore (Leonard et al., 1988; Revah et al., 1991; Karlin and Akabas, 1995; Xu and Akabas, 1996). Based on an electron microscopic comparison of the nACh receptor in the closed and open states, it has been postulated that the pore is maintained in the closed position by hydrophobic interactions between the conserved leucines located near the center of the kinked helical M2 motifs (Unwin, 1995).

This invariant M2 leucine residue first was mutated in the homomeric alpha 7 neuronal nACh receptor, where an increase was observed in sensitivity of the receptor to activation by ACh (Revah et al., 1991). In addition, a new single-channel conductance state appeared at low ACh concentrations, leading the authors to speculate that the mutation may have rendered the high affinity, nonconducting desensitized state ion conductive. An increase in agonist sensitivity also was observed when this leucine was mutated in the 5-HT3 (Yakel et al., 1993), muscle nACh (Filatov and White, 1995; Labarca et al., 1995), and GABAA (Chang et al., 1996) receptors.

The rho 1 GABA receptor subunit first was cloned from the human retina (Cutting et al., 1991). Expression of this subunit produced homomeric GABA receptors with pharmacological and activation properties distinct from those of typical heteromeric GABAA receptors (Cutting et al., 1991; Amin and Weiss, 1994) and more like those of GABAC receptors (Johnston, 1986; Sivilotti and Nistri, 1989). For example, the EC50 value for GABA-mediated activation in rho 1 receptors is approx 40-fold lower that than in alpha 1beta 2gamma 2 GABA receptors and the Hill coefficient is significantly greater (Kusama et al., 1993; Amin and Weiss, 1994) reflecting, at least in part, an increase in the number of agonist molecules required to gate the pore (Amin and Weiss, 1996). Moreover, rho 1 GABA receptors demonstrate very little desensitization during a maintained application of high concentrations of GABA (Amin and Weiss, 1994). Motivated by these unique rho 1 features, we set out to examine the potential role the conserved M2 leucine residue plays in the activation of homomeric rho 1 GABA receptors.

A series of amino acids differing in their relative size and hydrophobicity were substituted for the conserved M2 leucine (L301). In contrast to the results in other members of this receptor-operated superfamily, these mutations did not increase the agonist sensitivity of homomeric rho 1 receptors. Instead, substitution with either polar or small residues produced large resting conductances in oocytes expressing these mutant receptors. Ionic substitution studies and the effects of GABA receptor agonists and antagonists indicated that the large resting conductance resulted from the spontaneous opening of the mutant GABA receptors. The observation that mutation of this leucine can destabilize the closed state of the pore is consistent with the hypothesis that this residue may play a key role in the gating of the pore.

    Materials and Methods
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Site-directed mutagenesis and in vitro transcription. The human rho 1 cDNA [obtained by the polymerase chain reaction (Amin and Weiss, 1994)] was cloned into the pALTER-1 vector (Promega, Madison, WI), and oligonucleotide-mediated site-directed mutagenesis was achieved with the Altered Sites Kit (Promega). Successful mutagenesis was verified by sequencing (Sanger et al., 1977).

cDNAs were linearized with NheI, which leaves a several-hundred-base pair tail. Run-off capped cRNA then was transcribed from the linearized cDNAs using standard in vitro transcription procedures as described in the Megascript in vitro transcription instruction manual (Ambion, Austin, TX). Integrity, as well as yield, of the cRNA was verified on an agarose gel.

Oocyte isolation and cRNA injection. Xenopus laevis (Xenopus I, Ann Arbor, MI) were anesthetized by hypothermia, and oocytes were surgically removed from the frog and placed in a solution that consisted of 82.5 mM NaCl, 2.5 mM KCl, 5 mM HEPES, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4, 50 units/ml penicillin, and 50 µg/ml streptomycin, pH 7.5. Oocytes were dispersed in this solution minus Ca2+ plus 0.3% Collagenase A (Boehringer-Mannheim Biochemicals, Indianapolis, IN). After isolation, stage VI oocytes were thoroughly rinsed and maintained at 18°.

Micropipettes for injecting cRNA were pulled on a Sutter P87 horizontal puller, and the tips were cut off with the use of microscissors. cRNAs were diluted 2-20- fold with diethyl pyrocarbonate-treated water (depending on the yield of the in vitro transcription reaction). The cRNA was drawn up into the micropipette with negative pressure. To account for the batch-to-batch oocyte variability in expression level, we varied the injection volume such that 1-10 ng of cRNA of each construct was injected into a group of oocytes. In this way, we were ensured of having oocytes with the proper expression level for recording (typically 50-1000 nA maximum current). The cRNA was injected into the oocytes with a Nanoject delivery system (Drummond Scientific, Broomall, PA). We used the oocyte expression system because the long, stable recording times necessary to procure extensive dose-response relationships were not readily obtainable during patch-clamping of mammalian cells. Furthermore, preliminary studies indicate that high expression of the spontaneously opening channels seems to compromise the health of the human embryonic kidney 293 cells, and the expression level cannot be easily controlled when transfecting cDNA into mammalian cells. In contrast, we can easily control the expression level of recombinant proteins in oocytes by simply varying the amount of injected cRNA. By diluting the cRNA, as described above, we were able to keep the expression level of the mutant receptors in oocytes relatively low.

Recording. One to 3 days after injection, oocytes were placed on a 300-µm nylon mesh suspended in a small volume chamber (<100 µl). The oocyte was perfused continuously at a rate of 150-200 µl/sec with a solution consisting of 92.5 mM NaCl, 2.5 mM KCl, 5 mM HEPES, 1 mM CaCl2, and 1 mM MgCl2, pH 7.5, and briefly switched to the test solution that consisted of this same perfusion solution plus drug (e.g., GABA, GABA plus picrotoxin). For the chloride replacement experiments, 60 mM of the sodium chloride was replaced by 60 mM sodium isethionate. 3-APMPA was obtained from Tocris Cookson (St. Louis, MO). Picrotoxin was obtained from Sigma Chemical (St. Louis, MO).

Recording microelectrodes were fabricated with a P87 Sutter horizontal puller and filled with 3 M KCl. The electrodes had resistances of 1-3 MOmega . Standard two-electrode voltage-clamp techniques (GeneClamp 500; Axon Instruments, Foster City, CA) were used to record currents in response to application of agonist. Except when determining the current-voltage relationship, the membrane potential was clamped at -70 mV. Data were prefiltered at 10 Hz and played out on a Gould (Cleveland, OH) EasyGraf chart recorder during the experiment. The data also were digitized on-line using a Macintosh computer (Apple Computer, Cupertino, CA) equipped with a GW Instruments Data Acquisition Board (Somerville, MA). Digitization was carried out at 20 Hz using the software package Igor (Wavemetrics, Lake Oswego, OR) in conjunction with a set of macros written to drive the GW board (Bob Wyttenbach, Cornell University, Ithaca, NY). In addition, the currents were recorded on tape using the VR10B (Instrutech, Great Neck, NY) for off-line analysis.

The reversal potential of wild-type rho 1 GABA-mediated receptors presented in Fig. 1C and Table 1 was determined by varying the membrane potential during a continuous application of 3 µM GABA. This method more closely resembled the determination of reversal potentials in the spontaneously open mutant GABA receptors in that other membrane conductances contribute to the observed reversal potential. For example, in the chloride substitution experiments, the reversal potential determined using discrete pulses of GABA with the oocyte clamped at various membrane potentials was shifted positive by 26.5 ± 0.3 mV (predicted change in the Cl- equilibrium potential was 30 mV) compared with a shift of 14.1 ± 4.9 mV determined by varying the membrane potential during continuous GABA application. All the experimental observations in this study were repeated in at least two separate batches of oocytes.


View larger version (27K):
[in this window]
[in a new window]
  		Fig. 1.   Oocytes expressing mutant rho 1 GABA receptors have unusually large resting conductances. A, rho 1 receptors with substitutions of the conserved M2 leucine (L301) were expressed in Xenopus laevis oocytes. One to 3 days after cRNA injection, the current required to clamp the oocytes at -70 mV was measured. Substitution with either A, G, S, T, V, or Y required a significantly larger holding current than that of the wild-type receptor (wt). In contrast, the holding current for oocytes expressing either L301F or L301I mutants was not significantly different from that of the wild-type receptor. Values above the bars, number of oocytes for each case (mean ± standard error). B, Oocytes were injected with rho 1L301S cRNA, and 21 hr after injection, the holding current at -70 mV was measured using the two-electrode voltage-clamp. The average leakage current from 11 oocytes from the same batch were subtracted from the holding currents before plotting. Each point is the mean ± standard error from four to eight oocytes. Continuous line, least-squares fit of eq. 1 (see Materials and Methods) to the data points. Note that the holding current required to voltage clamp the oocytes at -70 mV increased as a function of the injected rho 1L301S cRNA. C, Current-voltage relationship of wild-type rho 1 GABA receptors in the absence of GABA (), wild-type rho 1 GABA receptors in the presence of 10 µM GABA (bullet ), and L301 mutants in the absence of GABA (all other filled symbols). Current values for the wild-type receptor in the absence of GABA and all the mutants were determined by clamping the oocyte at the indicated membrane potential and measuring the holding current. Thus, the determined reversal potential is influenced by other membrane conductances. To mimic this situation in the wild-type rho 1 receptor, GABA was applied continuously, and the same procedure as described above was carried out to determine the current-voltage relationship (see Materials and Methods). Continuous lines, linear regression to the data points. Reversal potentials are provided in Table 1.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1
Reversal potential and shift in reversal potential for wild-type and mutant rho 1 GABA receptors

The shift in reversal potential was determined by reducing the external chloride concentration from 99 to 39 mM. Values are mean ± standard deviation.

Data analysis. To quantify the agonist or antagonist sensitivity, each dose-response relationship was fit with one of the equations using a nonlinear least-squares method:
<UP>Activation: I</UP>=<FR><NU><UP>I</UP><SUB><UP>max</UP></SUB></NU><DE>1+(<UP>EC</UP><SUB>50</SUB>/[<UP>A</UP>])<SUP>n</SUP></DE></FR> (1)
<UP>Inhibition: I</UP>=<FR><NU><UP>I</UP><SUB><UP>max</UP></SUB></NU><DE>1+([<UP>A</UP>]/<UP>IC</UP><SUB>50</SUB>)<SUP>n</SUP></DE></FR> (2)
where I is the peak current at a given concentration of drug A; Imax is the maximum current response; EC50 or IC50 is the concentration of the drug yielding a half-maximal activation or inhibition of the GABA-activated current, respectively; and n is the Hill coefficient. The Kriskal-Wallis H test followed by a post hoc Mann-Whitney U test was used for statistical comparisons between wild-type and mutant parameters.

    Results
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Expression of rho 1 receptors with mutations at L301 resulted in unusually large resting currents in oocytes. As shown in Fig. 1A, oocytes expressing rho 1L301A, rho 1L301G, rho 1L301S, rho 1L301T, rho 1L301V, and rho 1L301Y, exhibited unusually large holding currents when the membrane potential was voltage clamped at -70 mV. The holding current at -70 mV in oocytes expressing rho 1L301F and rho 1L301I mutant receptors was not significantly different from that of wild-type receptors (Fig. 1A). Evidence that the increased holding currents resulted from the exogenously expressed mutant GABA receptors is provided in Fig. 1B; there was a dose-dependent increase in the holding current with increasing amounts of injected rho 1L301S cRNA. In >200 mutations we introduced into GABA receptors to date, many of which are in the M2, we never observed a large holding current as was evident with mutation of this conserved leucine.

We first considered the possibility that the large resting conductance was due to spontaneous openings of the mutant GABA receptors (i.e., opening in the absence of GABA). The data in Fig. 1C and Table 1 demonstrate that the reversal potential for this large resting conductance was the same as that of wild-type rho 1 GABA-mediated responses. Fig. 1C shows representative current-voltage relationships from oocytes expressing wild-type rho 1 receptors in the absence of GABA, wild-type rho 1 receptors during the continuous application of 10 µM GABA, and the mutants rho 1L301A, rho 1L301G, rho 1L301S, rho 1L301T, rho 1L301V, and rho 1L301Y in the absence of GABA. The reversal potential of the resting conductance in oocytes expressing wild-type rho 1 receptors in the absence of GABA was -53.7 ± 6.5 mV. The resting conductance in the mutant receptors demonstrated a reversal potential that was approximately -31 mV (range, -29 to -33 mV; Table 1), which was similar to the wild-type rho 1 reversal potential obtained during a continuous application of 10 µM GABA (-29.7 ± 3.9 mV).

To examine further the ionic basis of this large resting conductance, the external chloride concentration was reduced from 99 to 39 mM. This change in the chloride concentration should shift the chloride equilibrium potential positive by approx 30 mV. With chloride substitution, oocytes expressing wild-type rho 1 receptors exhibited only a very minimal shift in the reversal potential in the absence of GABA (Table 1), indicating that the oocyte native resting chloride conductance was minimal. In contrast, the reversal potential of the resting conductance for rho 1L301A, rho 1L301G, rho 1L301S, and rho 1L301T mutant receptors was shifted more positive by approx 14 mV (range, 13-15 mV). This shift is significantly less than the predicted 30-mV shift, most likely due to the contribution of other membrane conductances to the observed reversal potential (see Materials and Methods). In support of this, the wild-type reversal potential determined in the continuous presence of 10 µM GABA was shifted positive by a similar degree as the A, G, S, and T mutants (14.1 ± 4.9 mV). (The shift in reversal potential determined with pulses of GABA with the oocyte clamped at a range of membrane potentials was 26.5 ± 0.3 mV, much closer to the predicted shift for a chloride conductance.) The rho 1L301V and rho 1L301Y mutants demonstrated less of a shift in reversal potential with chloride substitution (Table 1), most likely due to the smaller resting conductance and therefore larger relative contribution of other native resting membrane conductances.

The data in Fig. 1 and Table 1 indicate that oocytes expressing rho 1L301A, rho 1L301G, rho 1L301S, rho 1L301T, rho 1L301V, and rho 1L301Y mutant receptors exhibit an increased conductance to chloride. We show that this large resting conductance is affected by selective GABA receptor agonists and antagonists that coupled with the data presented in Fig. 1 indicate that these particular substitutions produce spontaneously opening GABA receptors.

Picrotoxin reduced the large resting current in mutant rho 1 receptors. If the large resting conductances in oocytes expressing the rho 1L301A, rho 1L301G, rho 1L301S, rho 1L301T, rho 1L301V, and rho 1L301Y mutant receptors were due to spontaneous openings of the pore, they likely would be blocked by noncompetitive antagonists such as picrotoxin. Fig. 2A shows responses to a range of picrotoxin concentrations in an oocyte expressing rho 1L301A mutant receptors. (In Fig. 2A, the large resting current has been normalized to -1.0.) The application of picrotoxin reduced, in a concentration-dependent manner, the large inward current observed at -70 mV. Fig. 2B plots the fractional inhibition of the resting current as a function of the picrotoxin concentration for the rho 1L301A, rho 1L301G, rho 1L301S, rho 1L301T, and rho 1L301Y mutants. The rho 1L301V mutant exhibited no antagonism at concentrations as high as 3000 µM picrotoxin (data not shown). The application of these high concentrations of picrotoxin (3000 µM) did not antagonize the resting chloride conductance of oocytes expressing wild-type receptors (data not shown). The continuous lines are the best fits of eq. 2 to the data points (parameters are provided in Table 2). For purposes of comparison, the picrotoxin sensitivity of the wild-type rho 1 receptor (in the presence of 3 µM GABA) also is shown (dashed line).


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 2.   Picrotoxin (PTX) blocks the large holding current in mutant rho 1 receptors. A, An oocyte expressing rho 1L301A receptors was exposed to increasing concentrations of picrotoxin. Picrotoxin blocked the holding current in a dose-dependent manner. The large holding current was normalized to -1.0. B, The percentage block is plotted as a function of the picrotoxin concentration for the A, G, S, T, and Y mutants. The data were fit with an inhibition function (eq. 2) assuming complete block by picrotoxin. Parameters from this fit are provided in Table 2. Dashed line, fit to data from wild-type rho 1 receptors activated by 3 µM GABA. Note that the mutation impaired sensitivity to picrotoxin. Values are mean ± standard error.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2
Sensitivity of mutant receptors to picrotoxin

All values are mean ± standard deviation. Picrotoxin-mediated antagonism of the rho 1 wild-type receptor, as well as the L301F and L301I mutants, were determined on currents activated by 3 µM GABA. Antagonism of the resting conductance was determined in the other mutants. The L301I mutation exhibited a 10% inhibition with 1000 µM picrotoxin, whereas the L301V mutation exhibited no antagonism at picrotoxin concentrations as high as 3000 µM.

In comparison to the wild-type rho 1 receptor, much higher concentrations of picrotoxin were required to block the mutants. Thus, substitution of the leucine at position 301 impaired picrotoxin sensitivity. This is not entirely unexpected as several studies have demonstrated that mutations in the M2 motif can impair the antagonism of GABA or glycine receptors by picrotoxin (Pribilla et al., 1992; Zhang et al., 1994, 1995; Enz and Bormann, 1995; Gurley et al., 1995; Xu et al., 1995). Nevertheless, the ability of picrotoxin to block this large resting conductance further supports the conclusion that the L301 mutations produce spontaneously opening GABA receptors.

Mutant receptors that open in response to GABA. Currents in response to a range of GABA concentrations were examined in oocytes expressing wild-type and L301 mutant rho 1 receptors. Through these experiments, the mutants were divided into two categories. The first category, shown in Fig. 3, was composed of receptors that demonstrated inward currents in response to GABA. Fig. 3A shows GABA-mediated currents from an oocyte expressing wild-type rho 1 receptors and GABA-mediated currents for the rho 1L301F, rho 1L301I, rho 1L301V, and rho 1L301Y mutant receptors. Although the sensitivity of the mutants to GABA seemed to be similar to that of the wild-type receptor, the waveform of the currents clearly were altered. In addition, the L301V mutant demonstrated an initial outward current in response to GABA, which was most obvious at the lower concentrations (e.g., 0.03 and 0.1 µM GABA). This likely is a GABA-mediated antagonism of the spontaneously opening receptors that also was evident in several of the other mutants. Fig. 3B shows average GABA dose-response relationships. The lines representing wild-type and mutants are from the best fits of the Hill equation (eq. 1) to these data. The EC50 values for the rho 1L301F, rho 1L301I, rho 1L301V, and rho 1L301Y mutant receptors were similar to that of the wild-type receptor (Table 3), although the slope of the dose-response relationship was decreased significantly (see Hill coefficients in Table 3).


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 3.   GABA-mediated activation of wild-type (wt) rho 1L301F, rho 1L301I, rho 1L301V, and rho 1L301Y receptors. A, Currents in response to a range of GABA concentrations (top) are shown. Although the waveform of the currents vary between mutants (note different time scales), the mutant receptors have a GABA sensitivity similar to that of the wild-type receptor. Note that the L301V mutant shows an initial outward current most obvious at the lower GABA concentrations. This represents a GABA-mediated antagonism of spontaneously opening mutant receptors. B, Amplitude of the currents are plotted as a function of the GABA concentration. bullet , Wild-type rho 1 receptor. Dashed and continuous lines, best fit of the Hill equation (eq. 1) to the data points. Parameters from the fits are provided in Table 3. Values are mean ± standard error. For the measurement of amplitudes in the L301V mutant, the base-line was the level before GABA application. C, Examples of GABA-activated currents (3 µM GABA) in wild-type, L301F, L301I, and L301Y receptors. The current through the wild-type receptors does not decay during the continuous application of 3 µM GABA. In contrast, GABA-activated currents from rho 1L301F and rho 1L301Y receptors exhibited a decay during agonist application reminiscent of desensitization. The rho 1L301I mutant did not decay during GABA application, but channel closure on agonist removal (deactivation) was slowed considerably (t1/2 = 17.4 ± 1.3 sec for the wild-type and 190.8 ± 13.9 sec for rho 1L301I). An amplitude calibration bar is not shown because these currents were scaled to have the same peak.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 3
Activation of wild-type and mutant receptors by GABA

Parameters are mean ± standard deviation.

In addition to the decrease in the Hill coefficient, these mutations altered the waveform of the GABA-mediated currents (Fig. 3C). Wild-type rho 1 GABA receptors expressed in oocytes demonstrated little desensitization during a prolonged pulse of GABA. In contrast, both rho 1L301F and rho 1L301Y mutant receptors exhibited a marked decline in current during GABA application, reminiscent of desensitization. Although the current through the rho 1L301I mutant receptors did not decline during the application of GABA, the rate at which the current decayed on GABA removal (deactivation) was reduced drastically. For the rho 1 wild-type receptor, the current dropped to 50% of the peak amplitude in 17.4 ± 1.3 sec (five experiments) on GABA removal compared with 190.8 ± 13.9 sec (five experiments) for rho 1L301I. Thus, although the L301F, L301I, and L301Y substitutions did not drastically impair the sensitivity of the receptor to GABA (e.g., no significant change in the EC50), the gating kinetics of these mutants were altered (e.g., change in the Hill coefficient and current waveform).

Impaired picrotoxin sensitivity of mutant GABA receptors that are opened by GABA. Similar to the spontaneously opening A, G, S, T, V, and Y mutants, the rho 1L301I and rho 1L301F mutants exhibited an impaired picrotoxin sensitivity. Fig. 4A shows the effects of picrotoxin on wild-type rho 1 GABA receptors. The application of 3 µM GABA produced a large inward current that was blocked, in a concentration-dependent manner, by increasing concentrations of picrotoxin. Fig. 4A also shows the response of an oocyte expressing rho 1L301I receptors in response to the application of 1000 µM picrotoxin in the presence of 3 µM GABA. This extremely high concentration of picrotoxin blocked <10% of the GABA-activated current. Fig. 4B plots the fractional inhibition as a function of picrotoxin concentration for the wild-type, rho 1L301F, and rho 1L301I receptors. The phenylalanine substitution impaired picrotoxin sensitivity, although to a lesser extent than that of the isoleucine substitution. Fitting eq. 2 to these data yielded an IC50 value of 3.28 ± 0.43 µM and a Hill coefficient of 0.86 ± 0.03 for the rho 1 wild-type receptor and 119 ± 26 µM and 0.72 ± 0.04 for the IC50 value and Hill coefficient, respectively, of the rho 1L301F receptor. Due to the small amount of block, we could not reliably fit eq. 2 to the rho 1L301I data. Nevertheless, the rho 1L301F and rho 1L301I mutations induced approx 36- and >305-fold decreases in picrotoxin sensitivity compared with the wild-type receptor.


View larger version (17K):
[in this window]
[in a new window]
  		Fig. 4.   Antagonism of rho 1L301F and rho 1L301I receptors by picrotoxin. A, Trace on the left, increasing concentrations of picrotoxin applied to an oocyte expressing wild-type rho 1 GABA receptors during the continuous application of 3 µM GABA. Picrotoxin produced a dose-dependent inhibition of the GABA-activated current. Trace on the right, application of 1000 µM picrotoxin during the application of 3 µM GABA to an oocyte expressing the rho 1L301I mutant. This high concentration of picrotoxin blocked only a small fraction of the GABA-activated current. B, Percentage block of the GABA-activated current is plotted against the picrotoxin concentration for wild-type, L301F, and L301I receptors. Continuous lines, best fit of the inhibition equation to these data (eq. 2). The parameters from this fit are provided in Table 2. Dashed line (L301I), just connects the points because we were unable to fit eq. 2 to these data due to the small amount of block.   

Mutant receptors that close in response to GABA. Fig. 5A shows current responses to the application of GABA for the second category of mutants: rho 1L301A, rho 1L301G, rho 1L301S, and rho 1L301T. Surprisingly, oocytes expressing these mutant receptors demonstrated a dose-dependent increase in an apparent outward current in response to GABA as opposed to the typical inward current observed in oocytes expressing wild-type rho 1 GABA receptors (Fig. 3). To test whether this apparent outward current was associated with an increase or a decrease in membrane conductance, we applied hyperpolarizing voltage steps (-10 mV, 0.33 Hz) during the GABA application. Fig. 5B shows one representative experiment for the rho 1L301T mutant receptor. The application of GABA decreased the current step in response to the 10-mV voltage step, indicating a decrease in membrane conductance. Thus, the apparent outward currents in Fig. 5A actually were decreases in inward currents. Fig. 5C shows the dose dependence of this decrease in inward current for the L301A, L301G, L301S, and L301T mutants fit by eq. 2 (continuous lines). The parameters from these fits are provided in Table 4. The GABA IC50 values for the mutant receptors (range, 0.021-0.33 µM) were significantly lower than the EC50 value of the wild-type receptor (approx 1 µM). Given that the rho 1L301A, rho 1L301G, rho 1L301S, and rho 1L301T mutants exhibited the unusually large, picrotoxin-blockable, resting chloride conductance (Figs. 1 and 2), our interpretation of the results in Fig. 5 is that the binding of GABA actually closes the spontaneously opening mutant GABA receptors. Possible mechanisms of this antagonism are considered in Discussion.


View larger version (20K):
[in this window]
[in a new window]
  		Fig. 5.   GABA antagonizes the spontaneously opening GABA receptors. A, Currents in response to increasing concentrations of GABA were examined in oocytes expressing rho 1L301A, rho 1L301G, rho 1L301S, and rho 1L301T receptors. Note the concentration-dependent increase in an apparent outward current as opposed to the inward current expected at -70 mV. Calibration bar, 100 sec and 50 nA, 60 nA, 180 nA, and 150 nA, for the A, G, S, and T mutants, respectively. B, Hyperpolarizing voltage steps (10 mV) were applied to an oocyte expressing L301T receptors before, during, and after the application of 1 µM GABA. The current step in response to the voltage step decreased during the application of GABA, indicating a GABA-mediated decrease in conductance. Thus, the application of GABA closes ion channels. C, The fraction of current blocked is plotted against the GABA concentration and fitted by an inhibition equation (eq. 2, continuous lines). Values are mean ± standard error, and the parameters from the fits are provided in Table 4.         

                              
View this table:
[in this window]
[in a new window]
  		TABLE 4
Inhibition of spontaneous mutant receptors by GABA

Values are mean ± standard deviation.

The competitive antagonist 3-APMPA inhibits the GABA-mediated antagonism of spontaneously opening mutant receptors. Fig. 6A confirms that 3-APMPA is a competitive antagonist of wild-type rho 1 GABA receptors (Ragozzino et al., 1996). Represented in this figure are the wild-type GABA dose-response relationship in the absence of 3-APMPA and the GABA dose-response relationship, in the same three oocytes, in the presence of 10 µM 3-APMPA. This concentration of 3-APMPA shifted the EC50 value from 1.0 ± 0.1 to 12.7 ± 1.0 µM with no significant change in the maximum current. The Hill coefficient was decreased from 2.71 ± 0.13 to 1.9 ± 0.01, suggesting, in the strict sense, the antagonism may not be purely competitive. Nevertheless, in terms of the current amplitude, the actions of 3-APMPA were totally surmountable.


View larger version (14K):
[in this window]
[in a new window]
  		Fig. 6.   Actions of the competitive antagonist 3-APMPA on wild-type and mutant GABA rho 1 receptors. A, GABA dose-response relationship in the absence (filled symbols) and presence (stippled symbols) of 10 µM 3-APMPA. Continuous lines, best fit of the Hill equation (eq. 1) to the data points. The EC50 value and Hill coefficient in the absence of 3-APMPA were 1.0 ± 0.1 µM and 2.71 ± 0.13, respectively. The presence of 3-APMPA (10 µM) shifted the EC50 value to 12.7 ± 1.0 µM, and the Hill coefficient was reduced to 1.9 ± 0.01. The amplitude of the GABA-mediated currents in the presence of 3-APMPA was normalized to the maximum current in the absence of 3-APMPA, indicating the actions of this compound were totally surmountable by GABA. B, At low concentrations, 3-APMPA did not antagonize the spontaneously opening mutants: L301A, L301G, L301S, and L301T (data not shown). However, as the concentration exceeded 1 µM, 3-APMPA evoked an inward current on its own. Currents are shown in response to 1, 10, and 100 µM 3-APMPA for an oocyte expressing rho 1L301A receptors. Note the multiphasic activation of the current most obvious at 10 and 100 µM 3-APMPA. C, Dose-response relationship for the 3-APMPA-mediated activation. Values are mean ± standard error. Continuous line, merely connects the points. The cost of this compound prohibited an examination of higher concentrations to quantify the 3-APMPA sensitivity (e.g., EC50 value).

Classically, competitive antagonists are presumed to exert their actions by preventing the binding of the ligand to the receptor (e.g., overlapping binding sites of agonist and antagonist). Given that the rho 1L301A, rho 1L301G, rho 1L301S, and rho 1L301T receptors can open without the binding of GABA, we expected 3-APMPA to not antagonize the spontaneously opening GABA receptors, and this was indeed the case (data not shown). Surprisingly, at higher concentrations than necessary to antagonize wild-type GABA-activated currents (approx 1 µM) (Ragozzino et al., 1996), the application of 3-APMPA evoked a further inward current on its own (Fig. 6, B and C). The expense of this compound precluded a thorough determination of the dose-response relationship. Clearly, the EC50 value for 3-APMPA-mediated activation was >10 µM. 3-APMPA did not activate the wild-type rho 1 receptor (data not shown).

Although 3-APMPA did not antagonize the spontaneously opening mutant receptors, this compound did antagonize the GABA-mediated antagonism. Fig. 7A shows the antagonism of L301A mutant receptors by GABA, similar to that presented in Fig. 5. Also shown are GABA-mediated responses in the same oocyte but in the presence of 3 µM APMPA. The small inward currents in the presence of 0.03 and 0.1 µM GABA plus 3 µM 3-APMPA are due to the activation by 3-APMPA, as documented in Fig. 6B. In the presence of 3-APMPA, higher concentrations of GABA were required to antagonize the receptors. The average dose-response relationship in the absence and presence of 3 µM 3-APMPA for three oocytes is plotted in Fig. 7B along with the best fit of eq. 2 to these data. The IC50 value and Hill coefficient in the absence of 3-APMPA were 0.12 ± 0.01 µM and 2.73 ± 0.31, respectively. The presence of 3 µM 3-APMPA shifted the inhibition curve to the right with an IC50 value for GABA of 0.64 ± 0.02 µM and a Hill coefficient of 2.43 ± 0.13. These data indicate that 3-APMPA competitively antagonized the GABA-mediated inhibition of these spontaneously opening receptors, supporting the notion that the site at which GABA binds to antagonize the mutant receptors is similar, if not the same, as that to which GABA binds to activate the wild-type receptor.


View larger version (13K):
[in this window]
[in a new window]
  		Fig. 7.   3-APMPA antagonizes the GABA-mediated antagonism of spontaneously opening mutant receptors. A, Top row of traces, GABA-mediated currents in oocytes expressing rho 1L301A receptors. This is the GABA-mediated antagonism presented in Fig. 5. Bottom row of traces, GABA-mediated currents from the same oocyte but in the presence of 3 µM 3-APMPA. The small inward currents at the two lower concentrations are the result of direct activation by 3-APMPA. 3-APMPA shifted the sensitivity of the GABA-mediated antagonism to the right. B, Dose-response relationship for the GABA-mediated antagonism of rho 1L301A receptors in the absence and presence of 3-APMPA (3 µM). Continuous lines, best fit of eq. 2 (Materials and Methods) to the data points (mean ± standard error, three experiments). Error bars, smaller than the plotted symbols. The IC50 value and Hill coefficient for the GABA-mediated antagonism in the absence of 3-APMPA were 0.12 ± 0.01 µM and 2.73 ± 0.31, respectively. The presence of 3-APMPA shifted the IC50 value for GABA to 0.64 ± 0.02 µM, and the Hill coefficient was 2.43 ± 0.13. The amplitude of the responses in the presence of 3-APMPA was normalized to the maximum in the absence of 3-APMPA.

Effects of higher GABA concentrations on the spontaneously opening GABA receptors. Fig. 8A shows GABA-mediated currents for the rho 1L301A mutant receptor and includes higher GABA concentrations than those presented in Fig. 5. Up to 1 µM, the GABA-mediated antagonism is observed, as documented in Fig. 5. As the GABA concentration exceeded 1 µM, a slowly developing inward current became apparent. We interpret the current trace at 1000 µM GABA (shown on an expanded time scale in the bottom of Fig. 8A) as follows. With GABA application, the spontaneously open GABA receptors first close producing a decreasing inward current. With a slower time course, the receptors open, producing the observed inward current. On the initiation of GABA removal, the channels first close as the GABA concentration falls and then reopen in the absence of GABA. Such multiphasic responses also were observed for the rho 1L301G, rho 1L301S, and rho 1L301T mutant receptors. Fig. 8B plots the steady state amplitude of the current for an individual oocyte over the entire GABA concentration range (see figure legend for details of amplitude measurements). The continuous lines are the best fit of eqs. 1 and 2 to the GABA-mediated activation and inhibition, respectively. The EC50 value for the GABA-mediated activation of the L301A mutant was 127 ± 72 µM with a Hill coefficient of 0.66 ± 0.04 (four experiments). Parameters for the GABA-mediated antagonism were presented in Fig. 5 and Table 4.


View larger version (12K):
[in this window]
[in a new window]
  		Fig. 8.   At high concentrations, GABA activated the spontaneously opening mutant receptors. A, Currents in response to a wide range of GABA concentrations are shown from an oocyte expressing rho 1L301A mutant receptors. From 0.03 to 1 µM GABA, the antagonism of the spontaneously opening receptors was evident. At higher GABA concentrations, an increasing inward current became apparent. Bottom, current shows the response to 1000 µM GABA on an expanded time scale. The application of GABA initially blocked the receptors (i), but over a slower time course, the receptors were activated (ii). As the GABA concentration fell, the channels reclosed (iii) and finally reopened in the absence of GABA (iv). B, Complete dose-response relationship to GABA in an oocyte expressing rho 1L301A receptors. Filled symbols, GABA-mediated antagonism, and the base-line was the current level before GABA application. Shaded symbols, GABA-mediated activation, and the base-line was the extrapolated current level from the antagonism observed at low GABA concentrations. Continuous lines, best fits of eqs. 1 and 2 (see Materials and Methods) to the data points. The parameters from these fits are inhibition, IC50 = 0.11 µM with a Hill coefficient of 2.7; activation, EC50 = 132 with a Hill coefficient of 0.80. C, Currents in response to 100 µM GABA or 100 µM 3-APMPA from an oocyte expressing rho 1L301A mutant receptors. Note the similarity in the multiphasic activation kinetics.

The rising phase of this inward current (Fig. 8A, ii), similar to the 3-APMPA-mediated current shown in Fig. 6B (at concentrations of >10 µM), was extremely slow and multiphasic. Fig. 8C shows the similarity in the activation kinetics of current responses in the same oocyte to 100 µM GABA or 100 µM 3-APMPA. These data indicate complex gating kinetics and a similar mechanism of activation for these two compounds. The observation that 3-APMPA can activate the mutant receptors suggests GABA and 3-APMPA have overlapping (if not superimposable) binding sites. This also is supported by the close resemblance of the structures of GABA and 3-APMPA (Ragozzino et al., 1996).

    Discussion
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Comparison with other studies. This highly conserved M2 leucine residue was first mutated in the alpha 7 neuronal nACh receptor, where a leftward shift in the ACh dose-response relationship was observed (Revah, et al., 1991). The degree of shift in agonist sensitivity was dependent on the particular residue substituted at this position. In addition, the rate of desensitization was decreased and a new single-channel conductance state was observed at low ACh concentrations. The authors postulated that the mutation-induced increase in ACh sensitivity was the result of the desensitized state (which has a higher agonist affinity) becoming ion permeant. An increase in agonist sensitivity and rate of desensitization also was observed for mutation of the homologous leucine in 5-HT3 (Yakel et al., 1993), heteromeric muscle nACh (Filatov and White, 1995; Labarca et al., 1995), and alpha 1beta 2gamma 2 GABA receptors (Chang et al., 1996).

There are some similarities and some differences between our results in the homomeric rho 1 GABA receptor and the results observed in these other ligand-activated receptors. With regard to desensitization, mutation of the conserved leucine altered the rate of current decay during prolonged agonist application for alpha 7, 5-HT3, and rho 1 receptors. However, there are key differences among the receptors regarding the particular residue substituted at this position and the observed effect. For example, all substitutions in the alpha 7 receptor slowed the rate of current decay during a prolonged ACh application, with a decay rate order of L > F > V > T > S (Revah et al., 1991), a rough correlation with the degree of amino acid hydrophobicity of F approx  V approx  L > A > Y > T > S (Eisenberg et al., 1982). In contrast, the desensitization rate in 5-HT3 receptors was F > Y > A > L > T, which does not correlate well with the degree of hydrophobicity (Yakel et al., 1993). GABA-activated currents in oocytes expressing wild-type rho 1 receptors do not decay during a maintained application of GABA (Amin and Weiss,1994), although the L301F and L301Y substitutions produced rho 1 GABA-mediated currents that did decay during continuous GABA application with a rate of the order Y > F > L. Because only two of the substitutions produced this desensitizing phenotype in rho 1 receptors, it is difficult to draw a conclusion on the degree of hydrophobicity at position 301 and the rate of current decay.

Nevertheless, it is clear from the current study, as well as the studies with alpha 7 and 5-HT3 (Revah et al., 1991; Yakel et al., 1993), that the particular residue at this position can affect receptor desensitization. The differences in the results among the rho 1, alpha 7, and 5-HT3 receptors noted above, along with the pitfall that any amino acid substitution will alter both the hydrophobicity and size of the side chain, prevent a correlation on the hydrophobicity of the amino acid at this position and the process of receptor desensitization. The recently developed technique for introducing unnatural amino acids, by providing a larger array of possible substitute residues, may facilitate such an endeavor (Kearney et al., 1996). Furthermore, studies using small cells or membrane patches in which an agonist can be rapidly introduced and removed demonstrate that the current decay due to desensitization has multiple components (Verdoorn et al., 1990). In these cases, some of the components are faster than can be resolved in the current study because it takes a longer period of time to apply and remove agonists to oocytes. These limitations further complicate a correlation of amino acid characteristics and the rate of desensitization.

With regard to activation, the leucine mutations in the homomeric alpha 7 (Revah et al., 1991) and 5-HT3 (Yakel et al., 1993) receptors demonstrated an increase in agonist sensitivity that correlated with the degree of hydrophobicity (i.e., the lower the hydrophobicity, the greater was the leftward shift in the EC50 value). Similarly, in heteromeric receptors, mutation of this highly conserved leucine in the muscle nACh (Kearney et al., 1996) and alpha 1beta 2gamma 2 GABA receptors demonstrated an increase in agonist sensitivity with a substitution of the leucine in any one of the five subunits (Chang et al., 1996). Our results are distinct from these studies in that substitution of this leucine did not induce a leftward shift in the agonist dose-response relationship but rather substitutions of hydrophilic (Y, S, and T) or small (G, A, and V) residues produced spontaneously opening receptors. (Although in the limiting sense, opening in the absence of agonist could be considered an increase in agonist sensitivity.) Other substitutions (F, Y, and V) that decreased the EC50 values of the alpha 7 and 5-HT3 receptors did not alter the EC50 value of the GABA rho 1 receptor, although the Hill coefficient was depressed, perhaps indicating an effect on the cooperativity of activation. For alpha 1beta 2gamma 2 GABA receptors, oocytes expressing the leucine-mutant receptors had an increased resting conductance compared with wild-type alpha 1beta 2gamma 2 GABA receptors, leading the authors to speculate that this might be due to spontaneous openings of the pore (Chang et al., 1996). Tierney et al. (1996) demonstrated that substitution of this leucine in either the alpha 1 or beta 1 subunit does induce spontaneously opening alpha 1beta 1 GABA receptors expressed in SF9 cells. In addition, substitution of this leucine in the alpha  subunit of muscle nACh receptors (Auerbach et al., 1996) increased the frequency of occurrence of spontaneous openings (Jackson, 1984). Finally, spontaneously opening GABA receptors have been reported with expression of bovine alpha 2 subunits alone (Blair et al., 1988), rat beta 1 subunits alone (Sigel et al., 1989), and a combination of rat alpha 4 and beta  subunits (Khrestchatisky et al., 1989).

Mutations of the conserved leucine also impaired the ability of picrotoxin to antagonize the rho 1 receptor. Several studies have demonstrated that mutations in the M2 motif can impair the antagonism of GABA or glycine receptors by picrotoxin (Pribilla et al., 1992; Zhang et al., 1994, 1995; Enz and Bormann, 1995; Gurley et al., 1995; Xu et al., 1995). This impairment differed dramatically among the various L301 mutants. For example, the IC50 value for picrotoxin was approx 119 µM for rho 1L301F and >5450 µM for rho 1L301T. There was no obvious correlation between the picrotoxin sensitivity and either the mutant phenotype (GABA activated as in Fig. 3 versus spontaneously opening as in Fig. 5) or the particular residue substituted at position 301. The observation that the particular substitution can have widely different effects on the picrotoxin sensitivity suggests this highly conserved leucine may be closely associated with the site of action of picrotoxin. Furthermore, as is true for several other residues postulated to be crucial for the actions of picrotoxin (Pribilla et al., 1992; Zhang et al., 1994, 1995; Enz and Bormann, 1995; Gurley et al., 1995; Xu et al., 1995), the leucine at position 301 is presumed to reside on the alpha -helical M2 domain and line the ion pore (Xu and Akabas, 1996).

Speculations on the mechanism by which the mutations affect activation. Our observations indicate that mutations of the leucine residue at position 301 may have extensive effects on gating of the homomeric rho 1 receptor that are difficult to reconcile with simple kinetic models. In particular, and as elaborated on below, it seems unlikely that a simple change from a normal desensitized state into a conducting state could account for the data (Revah et al., 1991). Any interpretation must be speculative at this point, but some arguments can be made based on a qualitative survey of our results.

First, we consider the rapid reduction in current produced by low concentrations of GABA in the A, G, S, and T mutated subunits. This reduction could result from simple occlusion of the channel or by a mechanism involving more complex changes in kinetics. Simple occlusion is ruled out by several observations. First, the Hill coefficient for the antagonism by GABA is >1. A Hill coefficient of >1 would not be expected by a simple pore-blocking mechanism. Second, at higher GABA concentrations, the rapid reduction in current is replaced by a slow increase in current. This also is inconsistent with a continuing block. And, finally, the competitive antagonist 3-APMPA competitively antagonizes the reduction in current that also would not be expected for a pore-blocking mechanism.

Alternatively, the mutations may alter the gating kinetics of the receptor. Consider the wild-type activation mechanism in which three GABA molecules bind to fully activate the receptor (Amin and Weiss, 1996):
<UP>R</UP>⇌<UP>AR</UP>⇌<UP>A</UP><SUB>2</SUB><UP>R</UP>⇌<UP>A</UP><SUB>3</SUB><UP>R</UP>⇌<UP>A</UP><SUB>3</SUB><UP>R</UP>∗
where R is the receptor, A is the agonist molecule, AnR is the closed receptor bound with n agonist molecules, and A3R* is the open receptor with three bound agonist molecules. The kinetic scheme can be modified to account for the spontaneously opening mutant receptors as follows:
<AR><R><C><UP>R</UP></C></R><R><C><UP>⥮</UP></C></R><R><C><UP> R</UP>∗</C></R></AR><AR><R><C>⇌<UP>AR</UP>⇌<UP>A</UP><SUB>2</SUB><UP>R</UP>⇌<UP>A</UP><SUB>3</SUB><UP>R</UP>⇌<UP>A</UP><SUB>3</SUB><UP>R</UP>∗</C></R><R><C> </C></R><R><C> </C></R></AR>
where R* is the spontaneous open state. In the absence of GABA, the receptors would be in equilibrium between the R and R* states. In accounting for the antagonism at low GABA concentrations, the binding of GABA would drive the receptors from the R state into the singly bound (AR) and doubly bound (A2R) closed states. In this scenario, the binding of a single agonist molecule would be sufficient to stabilize the receptor in the closed conformation. The observation of a GABA-mediated channel closure seems in contradiction to a mechanism in which the binding of agonist stabilizes the subunit in an activated conformation, and when the requisite number of subunits are in this activated conformation, the receptor opens. This type of mechanism, in its simplest form, would not predict channel closing with agonist binding.

After the rapid reduction in current, GABA (at higher concentrations) produces a slow conductance increase when applied to receptors containing the A, G, S, and T mutant subunits. The fact that 3-APMPA on its own produces a slow increase in current with no rapid decrease would require that the processes of antagonism (discussed above) and activation produced by GABA would have to be uncoupled. The GABA-mediated activation observed at higher GABA concentrations could represent the normal pathway for channel activation with a decreased apparent sensitivity resulting from a decreased stability of the open state and/or a reduced cooperativity in agonist-mediated activation. A decrease in cooperativity is supported by the F, I, V, and Y mutations that demonstrate a dramatically reduced Hill coefficient for GABA-mediated activation (Table 3). Whatever the mechanism, normal gating must be altered since the resulting conductance increase resulting from GABA binding is both slower than normal and can be mimicked by 3-APMPA.

In summary, these observations are difficult to accommodate to a scheme that involves a unitary change, such as rendering a desensitized state conducting. Furthermore, the desensitized state should be nonresponsive to GABA. In fact, our spontaneously opening receptors do respond to GABA (i.e., they close). Instead, our data suggest that the energy landscape of receptor activation is altered in several respects by these mutations and a different mode of gating is revealed in the subunits with altered residues. Furthermore, they suggest that the kinetic states accessed in this mode do not map in a one-to-one fashion to states that can be discerned in the gating of the wild-type receptor.

Speculations on the role of this leucine in channel activation. The absolute conservation of the leucine at this position in the putative pore of all members of this receptor-operated family has focused considerable attention on its potential role in channel gating. Evidence suggests that the M2 domains of each of the five subunits line the pore (Leonard et al., 1988; Revah et al., 1991; White and Cohen, 1992; Karlin and Akabas, 1995; Xu and Akabas, 1996). In addition, evidence suggests these M2 domains are kinked helices and the invariant leucine located at the bend of all five subunits, through hydrophobic interactions with one another, prevents ion flux through the pore (Unwin, 1995). Destabilization of this leucine ring, prompted by agonist binding, weakens these interactions, allowing the leucine side-chains to rotate away from the central axis, thus opening the pore. This is only one model, and there is evidence using cysteine scanning mutagenesis that indicates cysteine residues substituted at positions intracellular to this putative gate-forming leucine are accessible in the absence of agonists. These studies place the gate more cytoplasmic than this conserved leucine (Xu and Akabas, 1996).

Muscle and neuronal nACh receptors, 5-HT3 receptors, and heteromeric alpha 1beta 2gamma 2 GABA receptors still open (albeit with an increased agonist sensitivity) when the leucine is substituted with small polar residues. As discussed by Karlin and Akabas (1995), if this leucine formed the gate, it seems unlikely that it would still be operable with such nonconservative substitutions. In fact, these mutations in the homomeric rho 1 receptor (as well as the alpha 1beta 1 and alpha 1beta 2gamma 2 GABA receptor; Tierney et al., 1996) do prevent the normal agonist-dependent gating of the pore. Consistent with the hydrophobic interactions involving the five leucines maintaining the channel in the closed conformation, substitution of a hydrophilic residue (serine or threonine) or a hydrophobic residue with a smaller side chain (alanine and glycine) destabilized the closed state of the pore and allowed the receptors to open spontaneously (Chang et al., 1996).

Finally, one substitution merits discussion on its own (L301I). This substitution increased the hydrophobicity (Eisenberg et al., 1982) without altering the size of the side chain. Our prediction, based on the leucine-ring hydrophobicity hypothesis (Unwin, 1995), would be that substitution with isoleucine should induce a rightward shift in the dose-response relationship because greater energy (contributed by agonist binding) would be required to disrupt these hydrophobic interactions and open the pore. In fact, the EC50 value of the L301I mutant was indistinguishable from that of the wild-type receptor, although the rate of channel closing on agonist removal (deactivation) was decreased dramatically (11-fold). One possible interpretation of this result is that the leucine, perhaps through hydrophobic interactions with neighboring domains, also is important for maintaining the pore in the open state. Substitution with isoleucine, due to its slightly greater hydrophobicity (Eisenberg et al., 1982), further stabilizes the open state of the pore and impairs channel closure.

In conclusion, although this study is unable to assign the gate to L301, our results suggest this highly conserved leucine may play an important role in GABA-mediated activation of homomeric rho 1 GABA receptors. Determination of the precise role of this leucine residue in ligand-mediated activation ultimately will depend on the high-resolution structural imaging of the GABA receptor.

    Acknowledgments

The authors acknowledge helpful comments from Joe Henry Steinbach, Virginia Wotring, and Michael Quick.

    Footnotes

Received July 15, 1997; Accepted November 12, 1997

This research was supported by National Institutes of Health Grant NS35291 and W.M. Keck Foundation Grant 931360.

Send reprint requests to: David S. Weiss, Ph.D., Department of Neurobiology, University of Alabama at Birmingham, 1719 Sixth Avenue South, CIRC 410, Birmingham AL 35294. E-mail: dweiss{at}nrc.uab.edu

    Abbreviations

GABA, gamma -aminobutyric acid; 3-APMPA, 3-aminopropyl(methyl)phosphinic acid; HEPES, 4-(2-hydroxyethyl)-1 piperazineethanesulfonic acid; M2, second membrane spanning domain; ACh, acetylcholine; nACh, nicotinic acetylcholine; 5-HT, 5-hydroxytryptamine.

    References
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

0026-895X/98/030511-13$3.00/0
MOLECULAR PHARMACOLOGY, 53:511-523 (1998).
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Physiol.Home page
J. Zhang, F. Xue, and Y. Chang
Agonist- and antagonist-induced conformational changes of loop F and their contributions to the {rho}1 GABA receptor function
J. Physiol., January 1, 2009; 587(1): 139 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Solt, D. Ruesch, S. A. Forman, P. A. Davies, and D. E. Raines
Differential Effects of Serotonin and Dopamine on Human 5-HT3A Receptor Kinetics: Interpretation within an Allosteric Kinetic Model
J. Neurosci., November 28, 2007; 27(48): 13151 - 13160.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Chen, K. A. Durkin, and J. E. Casida
Spontaneous Mobility of GABAA Receptor M2 Extracellular Half Relative to Noncompetitive Antagonist Action
J. Biol. Chem., December 15, 2006; 281(50): 38871 - 38878.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. Sedelnikova, B. E. Erkkila, H. Harris, S. O. Zakharkin, and D. S. Weiss
Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor
J. Physiol., December 1, 2006; 577(2): 569 - 577.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Chen, K. Reilly, and Y. Chang
Evolutionarily Conserved Allosteric Network in the Cys Loop Family of Ligand-gated Ion Channels Revealed by Statistical Covariance Analyses
J. Biol. Chem., June 30, 2006; 281(26): 18184 - 18192.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Chen, K. A. Durkin, and J. E. Casida
Structural model for {gamma}-aminobutyric acid receptor noncompetitive antagonist binding: Widely diverse structures fit the same site
PNAS, March 28, 2006; 103(13): 5185 - 5190.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
X.-Q. Hu and D. M Lovinger
Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+
J. Physiol., October 15, 2005; 568(2): 381 - 396.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Sedelnikova, C. D. Smith, S. O. Zakharkin, D. Davis, D. S. Weiss, and Y. Chang
Mapping the {rho}1 GABAC Receptor Agonist Binding Pocket: CONSTRUCTING A COMPLETE MODEL
J. Biol. Chem., January 14, 2005; 280(2): 1535 - 1542.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. G. Newell, R. A. McDevitt, and C. Czajkowski
Mutation of Glutamate 155 of the GABAA Receptor {beta}2 Subunit Produces a Spontaneously Open Channel: A Trigger for Channel Activation
J. Neurosci., December 15, 2004; 24(50): 11226 - 11235.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Miko, E. Werby, H. Sun, J. Healey, and L. Zhang
A TM2 Residue in the {beta}1 Subunit Determines Spontaneous Opening of Homomeric and Heteromeric {gamma}-Aminobutyric Acid-gated Ion Channels
J. Biol. Chem., May 28, 2004; 279(22): 22833 - 22840.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Filippova, V. E. Wotring, and D. S. Weiss
Evidence that the TM1-TM2 Loop Contributes to the {rho}1 GABA Receptor Pore
J. Biol. Chem., May 14, 2004; 279(20): 20906 - 20914.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. N. Goren, D. C. Reeves, and M. H. Akabas
Loose Protein Packing around the Extracellular Half of the GABAA Receptor {beta}1 Subunit M2 Channel-lining Segment
J. Biol. Chem., March 19, 2004; 279(12): 11198 - 11205.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. I. Torres and D. S. Weiss
Identification of a Tyrosine in the Agonist Binding Site of the Homomeric rho 1 gamma -Aminobutyric Acid (GABA) Receptor That, When Mutated, Produces Spontaneous Opening
J. Biol. Chem., November 8, 2002; 277(46): 43741 - 43748.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Scheller and S. A. Forman
Coupled and Uncoupled Gating and Desensitization Effects by Pore Domain Mutations in GABAA Receptors
J. Neurosci., October 1, 2002; 22(19): 8411 - 8421.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Panicker, H. Cruz, C. Arrabit, and P. A. Slesinger
Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel
J. Neurosci., March 1, 2002; 22(5): 1629 - 1639.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. C. Reeves, E. N. Goren, M. H. Akabas, and S. C. R. Lummis
Structural and Electrostatic Properties of the 5-HT3 Receptor Pore Revealed by Substituted Cysteine Accessibility Mutagenesis
J. Biol. Chem., November 2, 2001; 276(45): 42035 - 42042.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
J. P B Boorman, P. J GrootKormelink, and L. G Sivilotti
Stoichiometry of human recombinant neuronal nicotinic receptors containing the {beta}3 subunit expressed in Xenopus oocytes
J. Physiol., December 15, 2000; 529(3): 565 - 577.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. H. Steinbach, J. Bracamontes, L. Yu, P. Zhang, and D. F. Covey
Subunit-Specific Action of an Anticonvulsant Thiobutyrolactone on Recombinant Glycine Receptors Involves a Residue in the M2 Membrane-Spanning Region
Mol. Pharmacol., July 1, 2000; 58(1): 11 - 17.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
J. E. Dalziel, G. B. Cox, P. W. Gage, and B. Birnir
Mutating the Highly Conserved Second Membrane-Spanning Region 9' Leucine Residue in the alpha 1 or beta 1 Subunit Produces Subunit-Specific Changes in the Function of Human alpha 1beta 1 gamma -Aminobutyric AcidA Receptors
Mol. Pharmacol., May 1, 2000; 57(5): 875 - 882.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
T. R. Neelands, J. L. Fisher, M. Bianchi, and R. L. Macdonald
Spontaneous and gamma -Aminobutyric Acid (GABA)-Activated GABAA Receptor Channels Formed by epsilon  Subunit-Containing Isoforms
Mol. Pharmacol., January 1, 1999; 55(1): 168 - 178.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
A. Buhr, C. Wagner, K. Fuchs, W. Sieghart, and E. Sigel
Two Novel Residues in M2 of the gamma -Aminobutyric Acid Type A Receptor Affecting Gating by GABA and Picrotoxin Affinity
J. Biol. Chem., March 9, 2001; 276(11): 7775 - 7781.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. J. Boileau, J. G. Newell, and C. Czajkowski
GABAA Receptor beta 2 Tyr97 and Leu99 Line the GABA-binding Site. INSIGHTS INTO MECHANISMS OF AGONIST AND ANTAGONIST ACTIONS
J. Biol. Chem., January 18, 2002; 277(4): 2931 - 2937.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Y.
Right arrow Articles by Weiss, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Y.
Right arrow Articles by Weiss, D. S.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics